Ideally, though, the approval of a diagnostic would drive impulses for elafibranor, but elafibranor will need to deliver positive results to its phase 3 trial first.
Ideally, though, the approval of a diagnostic would drive eventual demand for elafibranor, but elafibranor will need to deliver positive results in its phase 3 trial first.